1. Home
  2. EBS vs FC Comparison

EBS vs FC Comparison

Compare EBS & FC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • EBS
  • FC
  • Stock Information
  • Founded
  • EBS 1998
  • FC 1983
  • Country
  • EBS United States
  • FC United States
  • Employees
  • EBS N/A
  • FC N/A
  • Industry
  • EBS Biotechnology: Pharmaceutical Preparations
  • FC Other Consumer Services
  • Sector
  • EBS Health Care
  • FC Consumer Discretionary
  • Exchange
  • EBS Nasdaq
  • FC Nasdaq
  • Market Cap
  • EBS 359.3M
  • FC 289.1M
  • IPO Year
  • EBS 2006
  • FC 1992
  • Fundamental
  • Price
  • EBS $7.16
  • FC $20.40
  • Analyst Decision
  • EBS Strong Buy
  • FC Strong Buy
  • Analyst Count
  • EBS 3
  • FC 2
  • Target Price
  • EBS $14.33
  • FC $31.00
  • AVG Volume (30 Days)
  • EBS 1.4M
  • FC 172.0K
  • Earning Date
  • EBS 08-06-2025
  • FC 07-02-2025
  • Dividend Yield
  • EBS N/A
  • FC N/A
  • EPS Growth
  • EBS N/A
  • FC N/A
  • EPS
  • EBS N/A
  • FC 0.81
  • Revenue
  • EBS $965,400,000.00
  • FC $279,943,000.00
  • Revenue This Year
  • EBS N/A
  • FC N/A
  • Revenue Next Year
  • EBS $16.15
  • FC $0.34
  • P/E Ratio
  • EBS N/A
  • FC $25.06
  • Revenue Growth
  • EBS N/A
  • FC N/A
  • 52 Week Low
  • EBS $4.02
  • FC $18.94
  • 52 Week High
  • EBS $15.10
  • FC $44.46
  • Technical
  • Relative Strength Index (RSI)
  • EBS 53.48
  • FC 43.72
  • Support Level
  • EBS $6.89
  • FC $19.17
  • Resistance Level
  • EBS $7.83
  • FC $20.90
  • Average True Range (ATR)
  • EBS 0.37
  • FC 0.77
  • MACD
  • EBS -0.00
  • FC 0.03
  • Stochastic Oscillator
  • EBS 42.80
  • FC 41.14

About EBS Emergent Biosolutions Inc.

Emergent BioSolutions Inc offers public health products to the government and healthcare providers. Company operates in three segments namely Commercial Product, MCM Products, and Services segment. The Commercial Product Segment consisting of Nasal Spray; the MCM Products Segment consisting of Anthrax-MCM products, Smallpox-MCM products and Other Products and the Services Segment consisting of Bioservices portfolio. The key revenue is generated through the commercial segment which consists of NARCAN and other commercial products.

About FC Franklin Covey Company

Franklin Covey Co is a company focused on organizational performance improvement. It focuses on providing time management and effectiveness training for individuals and corporations via online training as well as in-person workshops and events. The company provides training and consulting services in the areas of leadership, execution, productivity, trust, sales performance, customer loyalty, and educational improvement. It operates in the business segments of Direct Offices, Education division, and International Licensees. The company derives revenue from providing training and consulting services, and through the selling of books, audio media, and other related products. It has a business presence in the Australia, New Zealand, China, Japan, United Kingdom, Ireland, and Other countries.

Share on Social Networks: